Patent Issued for Fluorene derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as effective ingredient for preventing or treating HCV-related disease (USPTO 11261175)

Source :: Vaccine Weekly. March 23, 2022, 49
Publication Year :: 2022
Abstract: 2022 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Bae, Il Hak [...]

Subjects :: Protease inhibitors -- Intellectual property -- Methods
Antiviral agents -- Intellectual property -- Methods
Hepatitis C virus -- Methods
Vaccines -- Intellectual property -- Methods
Health

Tools